Related Tags >> Novartis FDA drug safety Roche

Genzyme News

Most Popular Genzyme Story

Who should Pfizer buy?

October 16, 2007 — 6:59am ET

Biogen Idec's sudden step onto the sale block has set off a frenzy of buyout talk. Will... Read more...

Genzyme Press Releases

Genzyme Begins Enrollment in Post-Marketing Study to Evaluate Use of Low Dose Fabrazyme Treatment for Fabry Disease
Science survey ranks top biopharma employers
Genzyme Corporation (GENZ) Marks Grand Opening of $125 Million Science Center; Among the First Research Laboratories to Earn Gol
Genzyme Corporation and Medicines for Malaria Venture Announce New Collaboration with Advinus Therapeutics to Accelerate Discove
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen

Latest Headlines

Genzyme, Isis solidify collaboration agreement
June 25, 2008
ALSO NOTED: Merck's Cordaptive fails to get U.S. approval; Medtronic sub faces FDA-imposed outage;
April 29, 2008
ALSO NOTED: Genzyme can't make Myozyme at Boston plant; Ranbaxy, Orchid forge drug-and-API deal;
April 22, 2008
FDA probes Roche, Novartis meds
April 11, 2008
ALSO NOTED: Pfizer loses second bid for journal records; Genzyme eyes 170-worker expansion in Ireland;
April 2, 2008
Shire stock jumps on Pfizer rumors
March 14, 2008
ALSO NOTED: Government could force doc disclosures; Barr sues Watson over Seasonique patent;
March 6, 2008
ALSO NOTED: Galvus gets EU committee nod; Merck appoints Vanderbilt official to board;
December 17, 2007
ALSO NOTED: Byetta data backs stand-alone app; Watson, Novartis settle suit;
December 7, 2007
SPOTLIGHT: Genzyme earnings skyrocket to $159M
October 25, 2007
Who should Pfizer buy?
October 16, 2007
Genentech, Roche rise on cancer sales
October 16, 2007
FDA warns Genzyme on French plant
October 3, 2007

Paid Research Reports